Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

The frustrating thing is that this could well be a $100 stock if management could execute a plan with good vision for the future. With only ~$300 million in the bank and more plans to spend $750 million buying HALO stock (bringing the total spent on buybacks to an astounding $2 Billion!!!), they are clearly not capable of any acquisition. The only thing left to hope for is new partnerships, but these are seemingly less and less likely.